Bristol-Myers Squibb (US)

Despite consolidation in the healthcare industry, Bristol-Myers Squibb has remained on the sidelines, waiting to make its move and quietly sharpening its focus on the pharmaceutical sector, and particularly on the biopharma sector. Once the world's #1 drug company, it has steadily been pushed down the rankings by mergers or aggressive growth among its competitors. During the 1990s, it sold off several of its non-core lines, followed in 2001 by its central Clairol business (to Procter & Gamble) as well as half of its medical devices portfolio, in order to concentrate on medicines. Several other non-core units were sold in 2008 and 2009, most significantly the Mead Johnson nutritionals division. Because of its size, BMS is regarded as a potential takeover target. The group entered tentative merger negotiations in 2007 with Sanofi-Aventis, the developer of its best-selling product, Plavix, which alone accounted for around a third of revenues in 2011. However, no agreement was reached. Plavix lost its patent towards the end of 2012, creating a significant challenge for BMS's future performance.

Which agencies handle advertising for Bristol-Myers Squibb? Find out more from the Account Assignments database.

Who are the competitors of Bristol-Myers Squibb? See Pharmaceutical Sector index for other companies

Subscribers only: Adbrands profile Account assignments and selected regional contact information

Adbrands Company Profiles provide a detailed analysis of the history and current operations of leading advertisers, agencies and brands worldwide, and include a critical summary which identifies key strengths and weaknesses. Adbrands Account Assignments tracks account management for the world's leading brands and companies, including details of which advertising agency handles which accounts in which countries for major markets.

Subscribers may access the following website links:

Bristol-Myers Squibb website

Plavix	Reyataz
Abilify	Atripla
Sprycel	Erbitux
Ixempra	Sustiva
Avapro	Pravachol
Coumadin	Onglyza

Bristol-Myers Squibb Worldwide

Click HERE to subscribe to Adbrands.net and access the profile and website links